{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T16:24:39Z","timestamp":1764433479228,"version":"3.44.0"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.thromres.2023.01.020","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T11:05:42Z","timestamp":1674471942000},"page":"127-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Additive effect of factor X on the structure and stability of activated factor VII-induced fibrin clot in hemophilic plasma with inhibitor"],"prefix":"10.1016","volume":"223","author":[{"given":"Eisuke","family":"Takami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoichi","family":"Kitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumi","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Fuchigami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotoshi","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2023.01.020_bb0005","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1111\/j.1365-2516.2011.02687.x","article-title":"Validity of assessing inhibitor development in haemophilia PUPs using registry data: the EUHASS project","volume":"18","author":"Fischer","year":"2012","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2023.01.020_bb0010","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/hae.12205","article-title":"A phase II clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics\/pharmacodynamics","volume":"19","author":"Shirahata","year":"2013","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2023.01.020_bb0015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.thromres.2009.12.010","article-title":"Combining FVIIa and FX into a mixture which imparts a unique thrombin generation potential to hemophilic plasma: an in vitro assessment of FVIIa\/FX mixture as an alternative bypassing agent","volume":"125","author":"Nakatomi","year":"2010","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2023.01.020_bb0020","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00001721-200501000-00010","article-title":"Modifications of flow measurement to determine fibrin gel permeability and the preliminary use in research and clinical materials","volume":"16","author":"He","year":"2005","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2023.01.020_bb0025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1182\/blood.V99.1.175","article-title":"Inhibition of fibrinolysis by recombinant factor FVIIa in plasma from patients with severe hemophilia A","volume":"99","author":"Lisman","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2023.01.020_bb0030","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1046\/j.1538-7836.2003.00242.x","article-title":"The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII\/J FIX","volume":"1","author":"He","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.01.020_bb0035","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00000441-196408000-00007","article-title":"Oral bleeding in hemophilia: treatment with epsilon-aminocaproic acid in the management of dental extractions in the hemophiliacs","volume":"248","author":"Corrigan","year":"1964","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.thromres.2023.01.020_bb0040","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1182\/blood-2018-01-828434","article-title":"Defective TAFI activation in hemophilia a mice is a major contributor to joint bleeding","volume":"132","author":"Wyseure","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2023.01.020_bb0045","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/jth.14656","article-title":"Thrombin activatable fibrinolysis inhibitor pathway alterations correlate with bleeding phenotype in patients with severe hemophilia A","volume":"18","author":"Semeraro","year":"2020","journal-title":"J. Thromb. Haemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823000208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823000208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:50:34Z","timestamp":1758736234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384823000208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":9,"alternative-id":["S0049384823000208"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2023.01.020","relation":{},"ISSN":["0049-3848"],"issn-type":[{"type":"print","value":"0049-3848"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Additive effect of factor X on the structure and stability of activated factor VII-induced fibrin clot in hemophilic plasma with inhibitor","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2023.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}